Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial

Wagemann, O., Liu, H., Wang, G., Shi, X., Bittner, T., Scelsi, M. A., Farlow, M. R., Clifford, D. B., Supnet-Bell, C., Santacruz, A. M., Aschenbrenner, A. J., Hassenstab, J. J., Benzinger, T. L. S., Gordon, B. A., Coalier, K. A., Cruchaga, C., Ibanez, L., Perrin, R. J., Xiong, C., … Masters, C. (2024). Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease. JAMA Neurology, 81(6), 582. https://doi.org/10.1001/jamaneurol.2024.0991
Authors:
Olivia Wagemann
Haiyan Liu
David B. Clifford
Charlene Supnet-Bell
Anna M. Santacruz
Andrew J. Aschenbrenner
Jason J. Hassenstab
Laura Ibanez
Richard J. Perrin
Yan Li
John C. Morris
Jorge Llibre-Guerra
Randall J. Bateman
Eric Mcdade
Johannes Levin
Guoqiao Wang
Xinyu Shi
Chengjie Xiong
Tobias Bittner
Marzia A. Scelsi
Martin R. Farlow
Tammie L. S. Benzinger
Brian A. Gordon
Kelley A. Coalier
Carlos Cruchaga
James J. Lah
Sarah B. Berman
Erik D. Roberson
Christopher H. van Dyck
Douglas Galasko
Serge Gauthier
Ging-Yuek R. Hsiung
William S. Brooks
Jeremie Pariente
Catherine J. Mummery
Nick C. Fox
Gregory S. Day
John M. Ringman
Patricio Chrem Mendez
Peter St. George-Hyslop
Kazushi Suzuki
Hamid R. Okhravi
Jasmeer Chhatwal
Mathias Jucker
John R. Sims
Karen C. Holdridge
Nicholas K. Proctor
Roy Yaari
Scott W. Andersen
Michele Mancini
Affiliated Authors:
Peter St. George-Hyslop
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1001/jamaneurol.2024.0991
PMID:
38683602
DOI:
10.1001/jamaneurol.2024.0991
Journal:
JAMA Neurology
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: